Pharmena S.A.

PHR

PLPHRMN00011

Personal Products

Market Closed - Warsaw S.E. Other stock markets 16:55:44 31/05/2024 BST			5-day change	1st Jan Change
5.92 ^PLN	-0.34%		-6.62%	-16.62%

05-24	Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-29	Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Pelion S.A. acquired an additional 4.09% stake in Pharmena Spolka Akcyjna.

December 27, 2015

Pelion S.A. (WSE:PEL) acquired an additional 4.09% stake in Pharmena Spolka Akcyjna (WSE:PHR) on December 23, 2015. Pelion acquired 0.36 million of Pharmena and now holds 50.01% stake together with its subsidiaries.

Pelion S.A. (WSE:PEL) completed the acquisition of an additional 4.09% stake in Pharmena Spolka Akcyjna (WSE:PHR) on December 23, 2015.

Latest news about Pharmena S.A.

Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-24	CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-27	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Grupo AC MARCA SL entered into an agreement to acquire Dermena from Pharmena S.A.	17/07/23	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/05/23	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/11/22	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22	CI
Pharmena S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/05/22	CI
Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/11/21	CI
Pharmena S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21	CI
Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	12/04/21	CI
Pharmena S.A. announced that it has received PLN 15.0858 million in funding from Pelion S.A.	29/11/20	CI
Pharmena S.A. announced that it expects to receive funding from Pelion S.A.	08/10/20	CI
Pharmena S.A. announced that it expects to receive PLN 0.299998 million in funding	28/08/18	CI
Cortria Corporation announced that it has received $0.2 million in funding from Pharmena S.A.	28/05/18	CI
Cortria Corporation announced that it has received $0.3 million in funding from Pharmena S.A.	29/10/17	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	24/04/17	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. sold 6.91% stake in Pharmena Spolka Akcyjna.	27/12/16	CI
Pelion S.A. acquired an additional 6.91% stake in Pharmena Spolka Akcyjna.	26/12/16	CI
Cortria Corporation announced that it has received $0.25 million in funding from Pharmena S.A.	23/08/16	CI
Pharmena SA Announces Earnings Results for the First Quarter of 2016	13/05/16	CI
Pelion S.A. acquired an additional 4.09% stake in Pharmena Spolka Akcyjna.	27/12/15	CI
Korporacja Inwestycyjna Polskiej Farmacji Sp. z o.o. acquired additional 3.98% stake in Pharmena Spolka Akcyjna.	03/12/13	CI

Chart Pharmena S.A.

Duration

Period

More charts

Company Profile

Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Companyâs products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

Sector

Personal Products

More about the company

Income Statement Evolution

More financial data

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
PHARMENA S.A.	-16.62%	16.73M
L'ORÉAL	+0.32%	262B
KAO CORPORATION	+18.76%	20.37B
GALDERMA GROUP AG	-.--%	19.29B
SHISEIDO COMPANY, LIMITED	+16.91%	12.64B
COTY INC.	-16.59%	8.94B
AMOREPACIFIC CORPORATION	+33.93%	8.62B
PROYA COSMETICS CO.,LTD.	+9.55%	5.93B
NATURA &CO HOLDING S.A.	-12.08%	3.92B
INTER PARFUMS, INC.	-16.83%	3.84B